DPYSL3 Antikörper (C-Term)
Kurzübersicht für DPYSL3 Antikörper (C-Term) (ABIN347041)
Target
Alle DPYSL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - C-Term
 - 
                                            
Spezifität
 - Reacts with 65 kDa CRMP-4 from human rat and mouse
 - 
                                            
Kreuzreaktivität (Details)
 - Do not react with CRMP-1, CRMP-2, CRMP-3 or CRMP-5.
 - 
                                            
Aufreinigung
 - Antiserum
 - 
                                            
Immunogen
 - A 15 residue synthetic peptide derived from C-terminal domain of human collapsing-response mediator
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
-IHC : 1/500 - WB :1/2 000 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Rekonstitution
 - Must be reconstituted in distilled water.
 - 
                                            
Lagerung
 - 4 °C/-20 °C
 - 
                                            
Informationen zur Lagerung
 - Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
 - 
                                            
Haltbarkeit
 - 24 months
 
 - 
                                            
 - 
    
- 
                                            : "A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS."    in: Human mutation, Vol. 34, Issue 7, pp. 953-60, (2013)         (PubMed).        
: "Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain." in: The Journal of comparative neurology, Vol. 486, Issue 1, pp. 1-17, (2005) (PubMed).
: "Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 21, Issue 18, pp. 7203-14, (2001) (PubMed).
: "Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes." in: The European journal of neuroscience, Vol. 11, Issue 12, pp. 4226-32, (2000) (PubMed).
: "Analysis of transglutaminase-catalyzed isopeptide bonds in paired helical filaments and neurofibrillary tangles from Alzheimer's disease." in: Methods in enzymology, Vol. 309, pp. 172-86, (1999) (PubMed).
 
 - 
                                            : "A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS."    in: Human mutation, Vol. 34, Issue 7, pp. 953-60, (2013)         (PubMed).        
 - 
    
- DPYSL3 (Dihydropyrimidinase-Like 3 (DPYSL3))
 - 
                                            
Andere Bezeichnung
 - Collapsin Response Mediator Protein 4 (CRMP-4)
 - 
                                            
Hintergrund
 - Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration
 - 
                                            
UniProt
 - Q14195
 
Target
 -